Heart transplantation: a history lesson of Lazarus

Abstract

One of the notable advances in modern day medicine is organ transplantation. None more so than the heart. A complex interaction between physiology, surgery and immunology that spanned decades, involving the hard work of many pioneers in their fields. We revisit the contributions of the pioneers as well as marvel at the paradigm shifts in medicine that have made heart transplantation safe and reproducible with in excess of 3000 transplants done yearly today.

Keywords

Heart transplantation / history / immunosuppression

References

[1] Bergan A.Ancient myth, modern reality: a brief history of transplantation..J Biocommun1997;24:2-9

[2] Salguero CP.Buddhism & Medicine in East Asian history..Religion Compass2014;8:239-50

[3] Linden PK.History of solid organ transplantation and organ donation..Crit Care Clin2009;25:165-84

[4] Goodrich JT.The ancient art of trepanation--a Greek Bronze Age “hole in the skull”..World Neurosurg2014;81:296-7

[5] Gutkind L.Many sleepless nights: the world of organ transplantation.1988;Norton & Company

[6] Hewitt CW,Lee WPA.Transplantation of composite tissue allografts.2008;New YorkSpringer

[7] Crawford AZ,McGhee CNJ.A brief history of corneal transplantation: from ancient to modern..Oman J Ophthalmol2013;6:S12-7 PMCID:PMC3872837

[8] Davis JS.Address of the president: the story of plastic surgery..Ann Surg1941;113:641-56 PMCID:PMC1385923

[9] Merchant J.Alexis Carrel (1873-1944): pioneer of vascular surgery and organ transplantation..Singapore Med J2013;54:602-3

[10] Aida L.Alexis Carrel (1873-1944): visionary vascular surgeon and pioneer in organ transplantation..J Med Biogr2014;22:172-5

[11] Sade RM.Transplantation at 100 years: Alexis Carrel, pioneer surgeon..Ann Thorac Surg2005;80:2415-8

[12] Shayan H.Organ transplantation: from myth to reality..J Invest Surg2001;14:135-8

[13] Cooper DKC,Platt JL.Xenotransplantation.1997;BerlinSpringer

[14] Barker CF.Historical overview of transplantation..Cold Spring Harb Perspect Med2013;3:a014977 PMCID:PMC3684003

[15] Dempster WJ.Kidney homotransplantation..Br J Surg1953;40:447-65

[16] Brent LB.A history of transplantation immunology.2005;Los Angeles Press

[17] Anderson D,Lampkin GH.The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle..Heredity1951;5:379

[18] Billingham RE,Medawar PB.Actively acquired tolerance of foreign cells..Nature1953;172:603-6

[19] Harrison JH,Murray JE.Renal homotransplantation in identical twins..Surg Forum1956;6:432-6

[20] Calne RY.The rejection of renal homografts. Inhibition in dogs by 6-mercaptopurine..Lancet1960;1:417-8

[21] Hamilton D,Starzl TE.A history of organ transplantation.2012;Pittsburgh Press

[22] Hill RB Jr,Starzl TE.Death after transplantation..Am J Med1967;42:327-34

[23] Waksman BH,Arnason BG.The use of specific “lymphocyte” antisera to inhibit hypersensitive reactions of the “delayed” type..J Exp Med1961;114:997-1022 PMCID:PMC2180405

[24] Woodruff MF.Effect of lymphocyte depletion by thoracic duct fistula and administration of antilymphocytic serum on the survival of skin homografts in rats..Nature1963;200:702

[25] Levey RH.Nature and mode of action of antilymphocytic antiserum..Proc Natl Acad Sci U S A1966;56:1130-7 PMCID:PMC220018

[26] Starzl TE,Porter KA,Cerilli GJ.The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation..Surg Gynecol Obstet1967;124:301-8 PMCID:PMC2675827

[27] Weisse AB.Medical odysseys.1991;New Jersey Press

[28] Weisse AB.Cardiac surgery: a century of progress..Tex Heart Inst J2011;38:486-90 PMCID:PMC3231540

[29] Lewis FJ.Closure of atrial septal defects with the aid of hypothermia; experimental accomplishments and the report of one successful case..Surgery1953;33:52-9

[30] Lillehei CW,Cohen M,Patton C.The first open-heart repairs of ventricular septal defect, atrioventricular communis, and tetralogy of Fallot using extracorporeal circulation by cross-circulation: a 30-year follow-up..Ann Thorac Surg1986;41:4-21

[31] Gibbon JH Jr.The development of the heart-lung apparatus..Am J Surg1978;135:608-19

[32] Kirklin JW,Patrick RT,Hetzel PS.Intracardiac surgery with the aid of a mechanical pump-oxygenator system (gibbon type): report of eight cases..Proc Staff Meet Mayo Clin1955;30:201-6

[33] Dewall RA,Lillehei CW,Varco RL.A simple, expendable, artificial oxygenator for open heart surgery..Surg Clin North Am1956;1025-34

[34] Konstantinov IE.Goetz: the surgeon who performed the first successful clinical coronary artery bypass operation..Ann Thorac Surg2000;69:1966-72

[35] Mann FC,Markowitz JJ.Transplantation of the intact mammalian heart..Arch Surg1933;26:219-24

[36] Shumacker HB Jr.A surgeon to remember: notes about Vladimir Demikhov..Ann Thorac Surg1994;58:1196-8

[37] Cooper DK.Experimental development of cardiac transplantation..BMJ1968;4:174-81

[38] Marcus E,Luisada AA.Homologous heart grafts; transplantation of the heart in dogs..Surg Forum1951;212-7

[39] Cooper DK.Transplantation of the heart and both lungs. I. Historical review..Thorax1969;24:383-90 PMCID:PMC472000

[40] Piciche M.Dawn and evolution of cardiac procedures.2013;New York

[41] Webb WR,Neely WA.Practical methods of homologous cardiac transplantation..J Thorac Surg1959;37:361-6

[42] Cass MH.Heart excision and replacement..Guys Hosp Rep1959;108:285-90

[43] Lower RR.Studies on orthotopic homotransplantation of the canine heart..Surg Forum1960;11:18-9

[44] Lower RR,Shumway NE.Homovital transplantation of the heart..J Thorac Cardiovasc Surg1961;41:196-204

[45] Reemtsma K,Iglesias F,Sayegh SF.Studies in homologous canine heart transplantation:prolongation of survival with a folic acid antagonist..Surgery1962;52:127-33

[46] Blumenstock DA,Collins JA,Hosbein JD.Prolonged survival of orthotopic homotransplants of the heart in animals treated with methotrexate..J Thorac Cardiovasc Surg1963;46:616-25

[47] A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to examine the definition of brain death..Jama1968;205:337-40

[48] Hardy JD,Chavez CM,Eraslan S.Heart transplantation in man. Developmental studies and report of a case..Jama1964;188:1132-40

[49] Kalra A,Hote M.The story of heart transplantation: from cape town to cape comorin..J Pract Cardiovasc Sci2016;2:120-5

[50] Barnard CN.The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town..S Afr Med J1967;41:1271-4

[51] Kantrowitz A,Joos H,Carstensen HE.Transplantation of the heart in an infant and an adult..Am J Cardiol1968;22:782-90

[52] Stinson EB,Schroeder JS,Shumway NE.Initial clinical experience with heart transplantation..Am J Cardiol1968;22:791-803

[53] Cooley DA.In memoriam: Donald N. Ross (1922-2014)..Tex Heart Inst J2014;41:456-7 PMCID:PMC4189342

[54] Cooley DA,Hallman GL,Nora JJ.Cardiac transplantation: general considerations and results..Ann Surg1969;169:892-905 PMCID:PMC1387574

[55] Patel R.Significance of the positive crossmatch test in kidney transplantation..N Engl J Med1969;280:735-9

[56] Patterson C.The history of heart transplantation..Am J Med Sci1997;314:190-7

[57] DiBardino DJ.The history and development of cardiac transplantation..Tex Heart Inst J1999;26:198-205 PMCID:PMC325641

[58] Griepp RB,Dong E,Shumway NE.Acute rejection of the allografted human heart: diagnosis and treatment..Ann Thorac Surg1971;12:113-26

[59] Clark DA,Griepp RB,Shumway NE.Cardiac transplantation in man: Vi. prognosis of patients selected for cardiac transplantation..Ann Intern Med1971;75:15-21

[60] Nishikawa T,Ishibashi-Ueda H.More than 50 years after Konno’s development of the endomyocardial biopsy..Int Heart J2017;58:840-6

[61] Caves PK,Graham AF,Grehl TM.Percutaneous transvenous endomyocardial biopsy..JAMA1973;225:288-91

[62] Melvin KR.Endomyocardial biopsy: its history, techniques and current indications..CMAJ1982;126:1381-6 PMCID:PMC1863164

[63] Caves P,Stinson E.Serial transvenous biopsy of the transplanted human heart improved management of acute rejection episodes..Lancet1974;303:821-6

[64] Borel JF,Gubler HU.Biological effects of cyclosporin A: a new antilymphocytic agent..Agents Actions1976;6:468-75

[65] Calne RY,Rolles K,Herbertson BM.Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A..Lancet1978;311:1183-5

[66] Morris T.The matter of the heart.2017;London

[67] Newton C.Interview: Sir Terence English..Bull Roy Coll Surg Engl2015;97:289-91

[68] English T.Follow your star.2011;Indiana

[69] Myers BD,Newton L,Perlroth M.Cyclosporine-associated chronic nephropathy..NEJM1984;311:699-705

[70] Patel JK.Tacrolimus in heart transplant recipients..BioDrugs2007;21:139-43

[71] European Multicentre Trial GCyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial..Lancet1983;2:986-9

[72] Starnes VA.Heart transplantation--Stanford experience..Clin Transpl1987;7-11

[73] Fung JJ.Tacrolimus and transplantation: a decade in review..Transplantation2004;77:S41-3

[74] Starzl TE,Fung J,Venkataramman R.FK 506 for liver, kidney, and pancreas transplantation..Lancet1989;2:1000-4 PMCID:PMC2966318

[75] Jurcevic S,Crisp S,Rinaldi M.A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine..Transplantation1998;65:1197-202

[76] Behr TM,Fischer P,Meiser B.Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A..Transplant Proc1998;30:1920-1

[77] Wang CH,Chou NK.Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral..Transplant Proc2004;36:2386-7

[78] Reichart B,Vigano M,Martinelli L.European Multicenter Tacrolimus (FK506) heart pilot study: one-year results--European Tacrolimus Multicenter Heart Study Group..J Heart Lung Transplant1998;17:775-81

[79] Taylor DO,Radovancevic B,Mentzer RM Jr.A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus..J Heart Lung Transplant1999;18:336-45

[80] Cooney GF,Choudhury S,Mueller EA.Comparative bioavailability of neoral and sandimmune in cardiac transplant recipients over 1 year..Transplant Proc1998;30:1892-4

[81] Eisen HJ,Davis SF,Mancini DM.Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation..Transplantation2001;71:70-8

[82] Grimm M,Yonan NA,Arizón Del Prado JM.Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients - a large European trial..Am J Transplant2006;6:1387-97

[83] Kobashigawa JA,Furukawa H,Yeatman L.Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients..J Heart Lung Transplant2006;25:434-9

[84] Allison AC.Mycophenolate mofetil and its mechanisms of action..Immunopharmacology2000;47:85-118

[85] Eisen HJ,Keogh A,Renlund D.Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients..J Heart Lung Transplant2005;24:517-25

[86] MacKeigan JP.Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex..Neuro-Oncology2015;17:1550-9 PMCID:PMC4633932

[87] Kobashigawa JA,Starling RC,Ross H.Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the everolimus versus mycophenolate mofetil randomized, multicenter trial..JACC Heart Fail2013;1:389-99

[88] Andreassen AK,Gustafsson F,Radegran G.Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial..Am J Transplant2014;14:1828-38

[89] Wlodarczyk Z,Salmela K,Margreiter R.Lipid metabolism in renal transplant patients receiving tacrolimus/sirolimus combination therapy..Transplant Proc2005;37:1871-3

[90] Lindenfeld J,Shakar SF,Lowes BD.Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs..Circulation2004;110:3858-65

[91] Tenderich G,Zittermann A,Berthold HK.Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients..Clin Transplant2007;21:536-43

[92] Wahlers T.Cytolytic induction therapy in heart and lung transplantation: the protagonist opinion..Transplant Proc1998;30:1100-3

[93] Odim J,Laks H,Gjertson D.Peri-operative renal function and outcome after orthotopic heart transplantation..J Heart Lung Transplant2006;25:162-6

[94] Wahlers T,Fleguth HG,Herrmann G.Adjusted triple drug immunosuppression and kidney function following heart transplantation..Transplant Proc1989;21:2492-3

[95] Kobashigawa JA,Russell SD,Zucker MJ.Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report..Am J Transplant2006;6:1377-86

[96] Kobashigawa J,Bara C,Dengler T.Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation..Transpl Infect Dis2013;15:150-62

[97] Euvrard S,Roussoulières A,Decullier E.Effect of everolimus on skin cancers in calcineurin inhihitor-treated heart transplant recipients..Transpl Int2010;23:855-7

[98] Eisen HJ,Starling RC,Kfoury A.Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial..Am J Transplant2013;13:1203-16

[99] Mehra MR,Hannan MM,Uber PA.The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update..J Heart Lung Transplant2016;35:1-23

[100] Ponikowski P,Anker SD,Cleland JGF.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC..Eur Heart J2016;37:2129-200

[101] Yancy CW,Bozkurt B,Casey DE Jr.2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America..Circulation2016;134:e282-93

[102] Dorent R,Goéminne C,Sebbag L.Assessment of potential heart donors: a statement from the French heart transplant community..Arch Cardiovasc Dis2017;

[103] Copeland JG.Only optimal donors should be accepted for heart transplantation: protagonist..J Heart Lung Transplant1995;14:1038-42

[104] Brock MV,Cameron DE,Conte JV.The changing profile of the cardiac donor..J Heart Lung Transplant2001;20:1005-9

[105] NHS Blood and TransplantTransplant Activity in the UK, 2016-2017.NHS Blood and Transplant2017;

[106] Cooper DK,Brink J,Klepetko W.Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases..J Heart Lung Transplant2000;19:1125-65

[107] Thompson JF,Cahill AP,Morris PJ.Kidney transplantation and seat belt legislation..BMJ (Clinical research ed)1983;287:1260-1 PMCID:PMC1549722

[108] Calil AM,Domingues Cde A.Mapping injuries in traffic accident victims: a literature review..Rev Lat Am Enfermagem2009;17:120-5

[109] Mercer P,Edmunds J,Baines J.Evaluating the donor pool: impact of using hearts from donors over the age of 49 years..Transplant Proc1997;29:3293-6

[110] Young JB.Age before beauty: the use of “older” donor hearts for cardiac transplantation..J Heart Lung Transplant1999;18:488-91

[111] Silva SFR,Nascimento AC,Albuquerque CA.Profile of organ donors in Ceará, northeastern Brazil, from 1998 to 2012..Transplant Proc2014;46:1692-4

[112] Rodrigues SdLL,Sardinha LAdC,Zambelli HJL.Profile of effective donors from organ and tissue procurement services..Rev Bras Ter Intensiva2014;26:21-7 PMCID:PMC4031888

[113] Drinkwater DC,Blitz A,Sabad A.Outcomes of patients undergoing transplantation with older donor hearts..J Heart Lung Transplant1996;15:684-91

[114] Bennett LE,Hosenpud JD.Transplantation with older donor hearts for presumed “stable” recipients: an analysis of the Joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry..J Heart Lung Transplant1998;17:901-5

[115] Massad MG,Hobbs RE,Vandervoort P.Bench repair of donor mitral valve before heart transplantation..Ann Thorac Surg1996;61:1833-5

[116] Marelli D,Fazio D,Moriguchi J.The use of donor hearts with left ventricular hypertrophy..J Heart Lung Transplant2000;19:496-503

[117] Hornik L,Wlost S,Minami K.Organs from donors with primary brain malignancy: the fate of cardiac allograft recipients..Transplant Proc2004;36:3133-7

[118] Banner NR,Clark AL,Cowburn PJ.UK guidelines for referral and assessment of adults for heart transplantation..Heart2011;97:1520-7

[119] Stewart GC.A history of devices as an alternative to heart transplantation..Heart Fail Clin2014;10:S1-12

[120] Wilhelm MJ.Long-term outcome following heart transplantation: current perspective..J Thorac Dis2015;7:549-51 PMCID:PMC4387387

[121] Lund LH,Kucheryavaya AY,Christie JD.The registry of the international society for heart and lung transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation..J Heart Lung Transplant2014;33:996-1008

[122] Burchill LJ.Heart transplantation in adult congenital heart disease..Heart2016;102:1871-7

[123] Lund LH,Dipchand AI,Kucheryavaya AY.The registry of the International Society for Heart and Lung Transplantation: thirty-third adult heart transplantation report-2016; focus theme: primary diagnostic indications for transplant..J Heart Lung Transplant2016;35:1158-69